Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Bray
Mark Buller

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Nature|November 19, 2010
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family membersStephane Daffis, Kristy J Szretter, Jill Schriewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Journal of Virology|September 29, 2005
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengeGuang Yang, Daniel C Pevear, Marc H Davies, et al.
The Journal of Infectious Diseases|October 11, 2003
Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaquesYvette Edghill-Smith, David Venzon, Tatiana Karpova, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Nature|November 19, 2010
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family membersStephane Daffis, Kristy J Szretter, Jill Schriewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Journal of Virology|September 29, 2005
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengeGuang Yang, Daniel C Pevear, Marc H Davies, et al.
The Journal of Infectious Diseases|October 11, 2003
Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaquesYvette Edghill-Smith, David Venzon, Tatiana Karpova, et al.
Pageof 14